Clinical trial
The 90% Effective Flow of High Flow Nasal Oxygenation During Deeply Sedated Bronchoscopy
NCT05298319 is registered in ClinicalTrials.gov with Zhejiang Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The 90% Effective Flow of High Flow Nasal Oxygenation During Deeply Sedated Bronchoscopy
- Lead sponsor
- Zhejiang Cancer Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2022
- Completion date
- August 31, 2022
- Enrollment
- 240 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.